Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Zhe Lin

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Diagnostics (Basel, Switzerland)|August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular CarcinomaBang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Anticancer Research|November 24, 2011
Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinomaYu-Yun Shao, Pei-Jer Chen, Zhong-Zhe Lin, et al.
BMC Cancer|May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort studyKuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Psychology & Health|October 1, 2020
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in lifeChia-Chen Hsieh, Chao-Chi Ho, Zhong-Zhe Lin, et al.
Psychosocial Intervention|January 9, 2025
The Mindful Compassion Program Integrated with Body-Mind-Spirit Empowerment for Reducing Depression in Lung Cancer Patient-Caregiver DyadsFei-Hsiu Hsiao, Chao-Chi Ho, Chong-Jen Yu, et al.
The Oncologist|May 25, 2012
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinomaWen-Yi Shau, Yu-Yun Shao, Yi-Chun Yeh, et al.
Cells|August 7, 2021
<i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular CarcinomaYu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2007
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatmentZhong-Zhe Lin, Chiun Hsu, Yeun-Chung Chang, et al.
The Oncologist|June 8, 2012
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapyZhong-Zhe Lin, Chiun Hsu, Fu-Chang Hu, et al.
Oncology|January 25, 2012
Survival of patients with small cell lung carcinoma in TaiwanYu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Diagnostics (Basel, Switzerland)|August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular CarcinomaBang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Anticancer Research|November 24, 2011
Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinomaYu-Yun Shao, Pei-Jer Chen, Zhong-Zhe Lin, et al.
BMC Cancer|May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort studyKuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Psychology & Health|October 1, 2020
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in lifeChia-Chen Hsieh, Chao-Chi Ho, Zhong-Zhe Lin, et al.
Psychosocial Intervention|January 9, 2025
The Mindful Compassion Program Integrated with Body-Mind-Spirit Empowerment for Reducing Depression in Lung Cancer Patient-Caregiver DyadsFei-Hsiu Hsiao, Chao-Chi Ho, Chong-Jen Yu, et al.
The Oncologist|May 25, 2012
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinomaWen-Yi Shau, Yu-Yun Shao, Yi-Chun Yeh, et al.
Cells|August 7, 2021
<i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular CarcinomaYu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2007
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatmentZhong-Zhe Lin, Chiun Hsu, Yeun-Chung Chang, et al.
The Oncologist|June 8, 2012
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapyZhong-Zhe Lin, Chiun Hsu, Fu-Chang Hu, et al.
Oncology|January 25, 2012
Survival of patients with small cell lung carcinoma in TaiwanYu-Hsuan Kuo, Zhong-Zhe Lin, Yen-Yun Yang, et al.
Pageof 7